We speculate that under SCA treatment, the PI3K–Akt–mTOR pathway was inhibited in breast cancer cells, and that the low activity of mTOR was not enough to exert an inhibitory effect on autophagy so that the autophagic process could be activated. This evidence concerns the gene AKT1 and breast carcinoma.